Results of dobutamine stress echocardiography in patients with Syndrome X

Luca Lanzarini, Mario Previtali, Raffaela Fetiveau, Arnaldo Poli

Research output: Contribution to journalArticle

Abstract

This study describes the results of Dobutamine stress echocardiography in 10 patients with Syndrome X. The diagnosis of Syndrome X was made on the basis of the presence of exertional angina, positive exercise stress test, negative ergonovine stress test and normal coronary arteries at angiography. All patients underwent Dobutamine stress echocardiography after interruption of any antianginal therapy. Dobutamine was infused starting with a dose of 5 mcg/kg/min over 3 minutes with incremental steps of 5 mcg/kg/min every 3 minutes up to a maximal dose of 40 mcg/kg/min. Two-dimensional echocardiography and 12-lead electrocardiography was monitored during the infusion of the drug. Nine patients received the maximal dose while one patient prematurely stopped the test for the occurrence of side effects. None of the ten patients developed segmental left ventricular wall motion abnormalities indicative of myocardial ischemia; ST-segment depression diagnostic for ischemia developed in 30% of patients; angina was elicited in one of these patients and in two additional patients. A hyperkinetic response to Dobutamine infusion involving all the segments of the left ventricle was observed both in patients with and without chest pain or electrocardiographic changes. In patients with Syndrome X Dobutamine induces a hyperkinetic left ventricular response indicative of normal contractile reserve despite the presence in some cases of angina and electrocardiographic signs of ischemia.

Original languageEnglish
Pages (from-to)145-148
Number of pages4
JournalThe International Journal of Cardiac Imaging
Volume10
Issue number2
DOIs
Publication statusPublished - Jun 1994

Fingerprint

Stress Echocardiography
Dobutamine
Exercise Test
Ischemia
Ergonovine
Chest Pain
Heart Ventricles
Myocardial Ischemia
Echocardiography
Coronary Vessels
Angiography
Electrocardiography

Keywords

  • dobutamine
  • stress-echocardiography
  • Syndrome X

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Results of dobutamine stress echocardiography in patients with Syndrome X. / Lanzarini, Luca; Previtali, Mario; Fetiveau, Raffaela; Poli, Arnaldo.

In: The International Journal of Cardiac Imaging, Vol. 10, No. 2, 06.1994, p. 145-148.

Research output: Contribution to journalArticle

Lanzarini, Luca ; Previtali, Mario ; Fetiveau, Raffaela ; Poli, Arnaldo. / Results of dobutamine stress echocardiography in patients with Syndrome X. In: The International Journal of Cardiac Imaging. 1994 ; Vol. 10, No. 2. pp. 145-148.
@article{4dd1acf9b9bd460c8b15caa54ce89f8e,
title = "Results of dobutamine stress echocardiography in patients with Syndrome X",
abstract = "This study describes the results of Dobutamine stress echocardiography in 10 patients with Syndrome X. The diagnosis of Syndrome X was made on the basis of the presence of exertional angina, positive exercise stress test, negative ergonovine stress test and normal coronary arteries at angiography. All patients underwent Dobutamine stress echocardiography after interruption of any antianginal therapy. Dobutamine was infused starting with a dose of 5 mcg/kg/min over 3 minutes with incremental steps of 5 mcg/kg/min every 3 minutes up to a maximal dose of 40 mcg/kg/min. Two-dimensional echocardiography and 12-lead electrocardiography was monitored during the infusion of the drug. Nine patients received the maximal dose while one patient prematurely stopped the test for the occurrence of side effects. None of the ten patients developed segmental left ventricular wall motion abnormalities indicative of myocardial ischemia; ST-segment depression diagnostic for ischemia developed in 30{\%} of patients; angina was elicited in one of these patients and in two additional patients. A hyperkinetic response to Dobutamine infusion involving all the segments of the left ventricle was observed both in patients with and without chest pain or electrocardiographic changes. In patients with Syndrome X Dobutamine induces a hyperkinetic left ventricular response indicative of normal contractile reserve despite the presence in some cases of angina and electrocardiographic signs of ischemia.",
keywords = "dobutamine, stress-echocardiography, Syndrome X",
author = "Luca Lanzarini and Mario Previtali and Raffaela Fetiveau and Arnaldo Poli",
year = "1994",
month = "6",
doi = "10.1007/BF01137710",
language = "English",
volume = "10",
pages = "145--148",
journal = "International Journal of Cardiovascular Imaging",
issn = "1569-5794",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Results of dobutamine stress echocardiography in patients with Syndrome X

AU - Lanzarini, Luca

AU - Previtali, Mario

AU - Fetiveau, Raffaela

AU - Poli, Arnaldo

PY - 1994/6

Y1 - 1994/6

N2 - This study describes the results of Dobutamine stress echocardiography in 10 patients with Syndrome X. The diagnosis of Syndrome X was made on the basis of the presence of exertional angina, positive exercise stress test, negative ergonovine stress test and normal coronary arteries at angiography. All patients underwent Dobutamine stress echocardiography after interruption of any antianginal therapy. Dobutamine was infused starting with a dose of 5 mcg/kg/min over 3 minutes with incremental steps of 5 mcg/kg/min every 3 minutes up to a maximal dose of 40 mcg/kg/min. Two-dimensional echocardiography and 12-lead electrocardiography was monitored during the infusion of the drug. Nine patients received the maximal dose while one patient prematurely stopped the test for the occurrence of side effects. None of the ten patients developed segmental left ventricular wall motion abnormalities indicative of myocardial ischemia; ST-segment depression diagnostic for ischemia developed in 30% of patients; angina was elicited in one of these patients and in two additional patients. A hyperkinetic response to Dobutamine infusion involving all the segments of the left ventricle was observed both in patients with and without chest pain or electrocardiographic changes. In patients with Syndrome X Dobutamine induces a hyperkinetic left ventricular response indicative of normal contractile reserve despite the presence in some cases of angina and electrocardiographic signs of ischemia.

AB - This study describes the results of Dobutamine stress echocardiography in 10 patients with Syndrome X. The diagnosis of Syndrome X was made on the basis of the presence of exertional angina, positive exercise stress test, negative ergonovine stress test and normal coronary arteries at angiography. All patients underwent Dobutamine stress echocardiography after interruption of any antianginal therapy. Dobutamine was infused starting with a dose of 5 mcg/kg/min over 3 minutes with incremental steps of 5 mcg/kg/min every 3 minutes up to a maximal dose of 40 mcg/kg/min. Two-dimensional echocardiography and 12-lead electrocardiography was monitored during the infusion of the drug. Nine patients received the maximal dose while one patient prematurely stopped the test for the occurrence of side effects. None of the ten patients developed segmental left ventricular wall motion abnormalities indicative of myocardial ischemia; ST-segment depression diagnostic for ischemia developed in 30% of patients; angina was elicited in one of these patients and in two additional patients. A hyperkinetic response to Dobutamine infusion involving all the segments of the left ventricle was observed both in patients with and without chest pain or electrocardiographic changes. In patients with Syndrome X Dobutamine induces a hyperkinetic left ventricular response indicative of normal contractile reserve despite the presence in some cases of angina and electrocardiographic signs of ischemia.

KW - dobutamine

KW - stress-echocardiography

KW - Syndrome X

UR - http://www.scopus.com/inward/record.url?scp=0027933557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027933557&partnerID=8YFLogxK

U2 - 10.1007/BF01137710

DO - 10.1007/BF01137710

M3 - Article

C2 - 7963753

AN - SCOPUS:0027933557

VL - 10

SP - 145

EP - 148

JO - International Journal of Cardiovascular Imaging

JF - International Journal of Cardiovascular Imaging

SN - 1569-5794

IS - 2

ER -